Abstract
Background: Current therapies for against inflammatory bowel disease (IBD) are sometimes limited by high costs, high toxicities and/or undesirable side effects, reasons for which new treatments are constantly being developed and studied. In this regards, an increasing mass of data has demonstrated that fecal transplantations and probiotic supplementations have shown promising effects and could be considered as adjunct IBD treatments to decrease some of the unwanted side effects caused by primary treatments. Furthermore, there is also mounting evidence that suggests that certain vitamins could provide antiinflammatory effects and it has been shown that certain strains of lactic acid bacteria (LAB), the most commonly used probiotic microorganisms, can produce biologically active forms of certain vitamins.
Objective: To discuss the potential role of the vitamin-producing LAB on intestinal inflammatory diseases.
Method: A thorough search of bibliographic databases for peer-reviewed research on the effect of vitamins produced by LAB on inflammatory processes was performed.
Results: There is mounting research that vitamin producing LAB could provide antiinflammatory effects.
Conclusion: The potential role of vitamin producing LAB was discussed not only because they could be used to decrease inflammation but also because they could provide the host with essential nutrients that are normally deficient in IBD patients due to altered intestinal morphologies.
Keywords: Colitis, folate, intestinal inflammation, lactic acid bacteria, mucositis, probiotics, riboflavin, vitamins.
Graphical Abstract
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Vitamin Producing Lactic Acid Bacteria as Complementary Treatments for Intestinal Inflammation
Volume: 17 Issue: 1
Author(s): Alejandra de Moreno de LeBlanc, Romina Levit, Graciela Savoy de Giori and Jean Guy LeBlanc*
Affiliation:
- Centro de Referencia para Lactobacilos (CERELA-CONICET). Chacabuco 145, (T4000ILC) San Miguel de Tucuman, Tucuman,Argentina
Keywords: Colitis, folate, intestinal inflammation, lactic acid bacteria, mucositis, probiotics, riboflavin, vitamins.
Abstract: Background: Current therapies for against inflammatory bowel disease (IBD) are sometimes limited by high costs, high toxicities and/or undesirable side effects, reasons for which new treatments are constantly being developed and studied. In this regards, an increasing mass of data has demonstrated that fecal transplantations and probiotic supplementations have shown promising effects and could be considered as adjunct IBD treatments to decrease some of the unwanted side effects caused by primary treatments. Furthermore, there is also mounting evidence that suggests that certain vitamins could provide antiinflammatory effects and it has been shown that certain strains of lactic acid bacteria (LAB), the most commonly used probiotic microorganisms, can produce biologically active forms of certain vitamins.
Objective: To discuss the potential role of the vitamin-producing LAB on intestinal inflammatory diseases.
Method: A thorough search of bibliographic databases for peer-reviewed research on the effect of vitamins produced by LAB on inflammatory processes was performed.
Results: There is mounting research that vitamin producing LAB could provide antiinflammatory effects.
Conclusion: The potential role of vitamin producing LAB was discussed not only because they could be used to decrease inflammation but also because they could provide the host with essential nutrients that are normally deficient in IBD patients due to altered intestinal morphologies.
Export Options
About this article
Cite this article as:
de Moreno de LeBlanc Alejandra , Levit Romina , de Giori Savoy Graciela and LeBlanc Guy Jean *, Vitamin Producing Lactic Acid Bacteria as Complementary Treatments for Intestinal Inflammation, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2018; 17 (1) . https://dx.doi.org/10.2174/1871523017666180502170659
DOI https://dx.doi.org/10.2174/1871523017666180502170659 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Matrix Metalloproteinases
Current Medicinal Chemistry Regulation of βAPP and PrPc Cleavage by α-Secretase: Mechanistic and Therapeutic Perspectives
Current Alzheimer Research Mechanisms and Immunological Roles of Apoptosis in Molluscs
Current Pharmaceutical Design A Comprehensive Review on Phytochemistry and Pharmacological Effects of Stinging Nettle (Urtica dioica)
Current Traditional Medicine Vaccine Ingredients: Components that Influence Vaccine Efficacy
Mini-Reviews in Medicinal Chemistry Trabectedin (Yondelis®) as a Therapeutic Option in Gynecological Cancers: A Focus on its Mechanisms of Action, Clinical Activity and Genomic Predictors of Drug Response
Current Drug Targets Dendritic Cells in Hepatitis Virus Infection: A Legatus Within
Current Immunology Reviews (Discontinued) The role of vitamin D towards immune tolerance in white adipose tissue (WAT)
Endocrine, Metabolic & Immune Disorders - Drug Targets The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Bio Distribution
Current Drug Metabolism Alefacept
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents
Recent Patents on Anti-Cancer Drug Discovery The Role of Bioreactors in Cartilage Tissue Engineering
Current Stem Cell Research & Therapy Regulation of Protective and Pathogenic Th17 Responses
Current Immunology Reviews (Discontinued) Hepatitis C Virus Proteins as Targets for Drug Development: The Role of Bioinformatics and Modelling
Current Drug Targets Type-3c Diabetes Mellitus, Diabetes of Exocrine Pancreas - An Update
Current Diabetes Reviews Atypical Presentation of Tardive Dyskinesia Associated with Risperidone Long-Acting Injection as Maintenance Treatment in Bipolar Affective Disorder: A Case Report
Current Drug Safety Editorial (Mini-Thematic Issue: Mold Allergens and Antigenic Epitopes Correlation with Fungal Diseases)
Current Protein & Peptide Science Perspective and Potential of A2A and A3 Adenosine Receptors as Therapeutic Targets for the Treatment of Rheumatoid Arthritis
Current Pharmaceutical Design Will Diverse Tat Interactions Lead to Novel Antiretroviral Drug Targets?
Current Drug Targets Cytokines in the Central Nervous System: Targets for Therapeutic Intervention
Current Drug Targets - CNS & Neurological Disorders